Birgit Krewer

487 total citations
18 papers, 407 citations indexed

About

Birgit Krewer is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Birgit Krewer has authored 18 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Organic Chemistry and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Birgit Krewer's work include Cancer therapeutics and mechanisms (11 papers), Chemical Synthesis and Analysis (8 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Birgit Krewer is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Chemical Synthesis and Analysis (8 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Birgit Krewer collaborates with scholars based in Germany and United States. Birgit Krewer's co-authors include Lutz F. Tietze, Ingrid Schuberth, Felix Major, Holm Frauendorf, Heiko Schuster, Jana Hof, Frauke Alves, Michael Müller, Gerhard Bringmann and Kianga Schmuck and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and International Journal of Molecular Sciences.

In The Last Decade

Birgit Krewer

18 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Krewer Germany 13 272 213 62 43 41 18 407
Rongbing Huang China 10 510 1.9× 266 1.2× 51 0.8× 79 1.8× 46 1.1× 11 584
Jens Buchardt Denmark 11 341 1.3× 169 0.8× 72 1.2× 31 0.7× 10 0.2× 19 457
Anh‐Tuan Pham Switzerland 9 215 0.8× 113 0.5× 48 0.8× 48 1.1× 14 0.3× 12 379
Eric W. P. Damen Netherlands 9 192 0.7× 166 0.8× 68 1.1× 26 0.6× 20 0.5× 13 368
Sarah Bregant France 15 408 1.5× 323 1.5× 113 1.8× 61 1.4× 17 0.4× 27 601
Jennifer L. Hickey Canada 14 376 1.4× 316 1.5× 63 1.0× 62 1.4× 21 0.5× 22 616
Hiu‐Chi Chong Hong Kong 7 236 0.9× 133 0.6× 72 1.2× 36 0.8× 151 3.7× 8 471
Ruben G.G. Leenders Netherlands 13 250 0.9× 130 0.6× 98 1.6× 51 1.2× 46 1.1× 21 401
Moritz Bosse Biskup Germany 9 393 1.4× 504 2.4× 46 0.7× 81 1.9× 18 0.4× 10 691
Pandurang V. Nikrad India 8 367 1.3× 256 1.2× 36 0.6× 74 1.7× 27 0.7× 9 507

Countries citing papers authored by Birgit Krewer

Since Specialization
Citations

This map shows the geographic impact of Birgit Krewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Krewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Krewer more than expected).

Fields of papers citing papers by Birgit Krewer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Krewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Krewer. The network helps show where Birgit Krewer may publish in the future.

Co-authorship network of co-authors of Birgit Krewer

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Krewer. A scholar is included among the top collaborators of Birgit Krewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Krewer. Birgit Krewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tietze, Lutz F., et al.. (2010). Glycosidic Prodrugs of Highly Potent Bifunctional Duocarmycin Derivatives for Selective Treatment of Cancer. Angewandte Chemie International Edition. 49(40). 7336–7339. 45 indexed citations
2.
Schuster, Heiko, Birgit Krewer, Jana Hof, et al.. (2010). Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity. Organic & Biomolecular Chemistry. 8(8). 1833–1833. 25 indexed citations
3.
Stritzker, Jochen, Ulrike Donat, Jana Hof, et al.. (2010). Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA. Cancer Gene Therapy. 18(1). 42–52. 27 indexed citations
4.
Tietze, Lutz F., et al.. (2010). Glycosidische Prodrugs hochpotenter difunktioneller Duocarmycin‐Derivate für eine selektive Tumortherapie. Angewandte Chemie. 122(40). 7494–7497. 18 indexed citations
5.
Tietze, Lutz F., Frank Behrendt, Felix Major, Birgit Krewer, & Jana Hof. (2010). Synthesis of Fluorescence‐Labelled Glycosidic Prodrugs Based on the Cytotoxic Antibiotic Duocarmycin. European Journal of Organic Chemistry. 2010(36). 6909–6921. 11 indexed citations
6.
Tietze, Lutz F., Birgit Krewer, & Holm Frauendorf. (2009). Investigation of the transformations of a novel anti-cancer agent combining HPLC, HPLC–MS and direct ESI–HRMS analyses. Analytical and Bioanalytical Chemistry. 395(2). 437–448. 11 indexed citations
7.
Tietze, Lutz F. & Birgit Krewer. (2009). Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies. Anti-Cancer Agents in Medicinal Chemistry. 9(3). 304–325. 24 indexed citations
8.
Tietze, Lutz F. & Birgit Krewer. (2009). Antibody‐Directed Enzyme Prodrug Therapy: A Promising Approach for a Selective Treatment of Cancer Based on Prodrugs and Monoclonal Antibodies. Chemical Biology & Drug Design. 74(3). 205–211. 47 indexed citations
9.
Tietze, Lutz F., Birgit Krewer, Jana Hof, Holm Frauendorf, & Ingrid Schuberth. (2009). Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065. Toxins. 1(2). 134–150. 17 indexed citations
10.
Tietze, Lutz F., Birgit Krewer, & Holm Frauendorf. (2009). Probing the Mechanism of Action of Potential Anticancer Agents at a Molecular Level Using Electrospray Ionisation Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. European Journal of Mass Spectrometry. 15(5). 661–672. 12 indexed citations
11.
Tietze, Lutz F., Birgit Krewer, Felix Major, & Ingrid Schuberth. (2009). CD-Spectroscopy As a Powerful Tool for Investigating the Mode of Action of Unmodified Drugs in Live Cells. Journal of the American Chemical Society. 131(36). 13031–13036. 22 indexed citations
12.
Tietze, Lutz F., Birgit Krewer, Michael Müller, et al.. (2008). Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy. ChemMedChem. 3(12). 1946–1955. 23 indexed citations
13.
Tietze, Lutz F., Olaf Panknin, Felix Major, & Birgit Krewer. (2008). Synthesis of a Novel Pentagastrin‐Drug Conjugate for a Targeted Tumor Therapy. Chemistry - A European Journal. 14(9). 2811–2818. 10 indexed citations
14.
Tietze, Lutz F., Heiko Schuster, Birgit Krewer, & Ingrid Schuberth. (2008). Synthesis and Biological Studies of Different Duocarmycin Based Glycosidic Prodrugs for Their Use in the Antibody-Directed Enzyme Prodrug Therapy. Journal of Medicinal Chemistry. 52(2). 537–543. 38 indexed citations
15.
Tietze, Lutz F., Olaf Panknin, Birgit Krewer, Felix Major, & Ingrid Schuberth. (2008). Synthesis and Biological Evaluation of a Novel Pentagastrin- Toxin Conjugate Designed for a Targeted Prodrug Monotherapy of Cancer. International Journal of Molecular Sciences. 9(5). 821–837. 6 indexed citations
16.
Tietze, Lutz F., Felix Major, Ingrid Schuberth, et al.. (2007). Selective Treatment of Cancer: Synthesis, Biological Evaluation and Structural Elucidation of Novel Analogues of the Antibiotic CC‐1065 and the Duocarmycins. Chemistry - A European Journal. 13(16). 4396–4409. 33 indexed citations
17.
Tietze, Lutz F., Birgit Krewer, Holm Frauendorf, Felix Major, & Ingrid Schuberth. (2006). Investigation of Reactivity and Selectivity of DNA‐Alkylating Duocarmycin Analogues by High‐Resolution Mass Spectrometry. Angewandte Chemie International Edition. 45(39). 6570–6574. 22 indexed citations
18.
Tietze, Lutz F., Birgit Krewer, Holm Frauendorf, Felix Major, & Ingrid Schuberth. (2006). Untersuchung der Reaktivität und Selektivität DNA‐alkylierender Duocarmycin‐Analoga mittels hochauflösender Massenspektrometrie. Angewandte Chemie. 118(39). 6720–6724. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongbing Huang Breakdown of academic impact, for papers by Jens Buchardt Breakdown of academic impact, for papers by Anh‐Tuan Pham Breakdown of academic impact, for papers by Eric W. P. Damen Breakdown of academic impact, for papers by Sarah Bregant Breakdown of academic impact, for papers by Jennifer L. Hickey Breakdown of academic impact, for papers by Hiu‐Chi Chong Breakdown of academic impact, for papers by Ruben G.G. Leenders Breakdown of academic impact, for papers by Moritz Bosse Biskup Breakdown of academic impact, for papers by Pandurang V. Nikrad
Rankless by CCL
2026